(1R,2R)-2-((Benzyloxy)methyl)cyclopent-3-en-1-yl 4-nitrobenzoate is an intermediate in the synthesis of Entecavir (E558900), an oral antiviral drug used in the treatment of hepatitis B infection.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.